BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell therapeutics for neurodegenerative diseases, announced the appointment of Hartoun Hartounian Ph.D. as its...
Abzena, the leading end-to-end integrated contract and development manufacturing organization for complex biologics and bioconjugates, and Argonaut Manufacturing Services, Inc., a cGMP CDMO serving...
The Board of Directors of Regel Therapeutics, a gene regulation company, announced that Stephen J. Farr, PhD, begins as Chief Executive Officer (CEO).
Dr. Farr served...
Small molecule drug discovery acceleration experts and DNA-encoded library (DEL) technology pioneers X-Chem, Inc. welcomes Paul Davie as Chief Business Officer. He will lead global business development,...
Critical Path Institute (C-Path), a leader in forming collaborations that accelerate drug development, and Centogene N.V., the essential life science partner for data-driven answers...
